Literature DB >> 9798870

Cystic fibrosis: predictors of accelerated decline and distribution of disease in 230 patients.

R H Cleveland1, A S Neish, D Zurakowski, D P Nichols, M E Wohl, A A Colin.   

Abstract

OBJECTIVE: The purpose of this study was to determine predictors of accelerated deterioration in radiographic manifestations of cystic fibrosis. The incidence and distribution of focally accentuated disease were also studied.
MATERIALS AND METHODS: From 230 patients, 3038 chest radiographs were scored using the Brasfield system. Scores were plotted against age, and a single age-based severity curve was created. Specific observations (at least one episode in the first 5 years of life of air trapping, linear markings, nodular cystic lesions, or large lesions) were assessed to determine predictors of accelerated decline in scores compared with the aggregate scores plotted in the age-based severity curve. Specific observations were noted as present or absent and graded as to severity. A specific observation was counted as present if seen on at least one occasion. (The number of occasions on which the observation was made did not affect statistical analysis.) We also evaluated the distribution of lung disease by assessing the severity and nature of disease through specific lobar distribution.
RESULTS: Males showed a slightly greater rate of radiologic decline. Early development of air trapping or bronchiectasis was associated with an accelerated rate of decline over time. Lobe-dominant disease occurred in one third of all images and in two thirds of the patients. It varied with age in its incidence, location, and etiology.
CONCLUSION: Hyperinflation or bronchiectasis that occurs before age 5 is associated with accelerated radiographic deterioration. The incidence and location of lobe-dominant disease varied with age in these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9798870     DOI: 10.2214/ajr.171.5.9798870

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Regional differences in the evolution of lung disease in children with cystic fibrosis.

Authors:  Zhanhai Li; Don B Sanders; Michael J Rock; Michael R Kosorok; Jannette Collins; Christopher G Green; Alan S Brody; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2011-12-07

2.  Pulmonary radiographic findings in young children with cystic fibrosis.

Authors:  Jesiana Ferreira Pedrosa; Cássio da Cunha Ibiapina; Cristina Gonçalves Alvim; Paulo Augusto Moreira Camargos; Fabiana Paiva Martins; Elizabet Vilar Guimarães; Renata Marcos Bedran
Journal:  Pediatr Radiol       Date:  2014-07-22

3.  Similar performance of Brasfield and Wisconsin scoring systems in young children with cystic fibrosis.

Authors:  Robert H Cleveland; Gregory S Sawicki; Catherine Stamoulis
Journal:  Pediatr Radiol       Date:  2015-05-29

4.  Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report.

Authors:  Hara Levy; Carolynn L Cannon; Daniel Asher; Christopher García; Robert H Cleveland; Gerald B Pier; Michael R Knowles; Andrew A Colin
Journal:  J Med Case Rep       Date:  2010-04-26

5.  Brasfield and Wisconsin scoring systems have equal value as outcome assessment tools of cystic fibrosis lung disease.

Authors:  Robert H Cleveland; Catherine Stamoulis; Gregory Sawicki; Emma Kelliher; Evan J Zucker; Christopher Wood; David Zurakowski; Edward Lee
Journal:  Pediatr Radiol       Date:  2013-12-27

6.  Sleep-disordered breathing in cystic fibrosis.

Authors:  Aarti Shakkottai; Samya Z Nasr; Fauziya Hassan; Sanaya Irani; Louise M O'Brien; Ronald D Chervin
Journal:  Sleep Med       Date:  2020-06-05       Impact factor: 3.492

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.